Thermo Fisher Scientific
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer.
Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them.
Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
Stock Symbol: TMO
1632 articles about Thermo Fisher Scientific
-
Thermo Fisher Scientific Hosts 2023 Investor Day
5/24/2023
Thermo Fisher Scientific Inc. hosted its 2023 Investor Day today and provided an in-depth review of the Company’s proven growth strategy and its industry-leading businesses.
-
Thermo Fisher Scientific Declares Quarterly Dividend - May 24, 2023
5/24/2023
Thermo Fisher Scientific Inc., the world leader in serving science, announced that its Board of Directors authorized a quarterly cash dividend of $0.35 per common share, payable on July 14, 2023, to shareholders of record as of June 15, 2023.
-
Thermo Fisher Scientific to Present at Bernstein 39th Annual Strategic Decisions Conference on May 31st, 2023
5/22/2023
Thermo Fisher Scientific to Present at Bernstein 39th Annual Strategic Decisions Conference on May 31st , 2023.
-
Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
5/19/2023
Thermo Fisher Scientific, the world leader in serving science, has opened a new sterile drug facility in Singapore that will better enable customers to deliver new medicines and vaccines in the Asia-Pacific market.
-
Thermo Fisher Scientific Announces FDA Clearance of Breakthrough Immunoassays to Aid in the Risk Assessment of Preeclampsia
5/19/2023
Thermo Fisher Scientific Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the Thermo Scientific B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR novel biomarkers, the first and only immunoassays to receive breakthrough designation and clearance for the risk assessment and clinical management of preeclampsia, a severe pregnancy complication.
-
Thermo Fisher Scientific Releases 2022 Corporate Social Responsibility Report
5/17/2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today released its annual Corporate Social Responsibility (CSR) report.
-
Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next-Generation Sequencing-Based Testing for Cancer Patients in International Markets
5/9/2023
Pfizer and Thermo Fisher Scientific Inc. (NYSE: TMO) today announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East and Asia where advanced genomic testing has previously been limited or unavailable.
-
In addition to promoting their brands, companies say their funding initiatives give them access to the expertise of top researchers and contribute to society.
-
Thermo Fisher Scientific to Present at BofA Securities 2023 Healthcare Conference on May 10th, 2023
5/2/2023
Thermo Fisher Scientific Inc. announced that Marc N. Casper, chairman, president and chief executive officer, will present at the BofA Securities 2023 Healthcare Conference on Wednesday, May 10, 2023 at 11:00 a.m. (EDT).
-
Thermo Fisher Scientific Reports First Quarter 2023 Results
4/26/2023
Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the first quarter ended April 1, 2023.
-
Choose your raw materials wisely
-
Devyser enters agreement with Thermo Fisher Scientific for commercialization of Devyser's post-transplant NGS products
4/24/2023
Devyser Diagnostics AB announced that the company has signed an exclusive collaboration and distribution agreement with Thermo Fisher Scientific.
-
OpGen Enters Into Distribution Agreement for Unyvero in the U.S. with Fisher Healthcare
4/18/2023
OpGen, Inc. announced that the Company has entered into a non-exclusive distribution agreement with Fisher Healthcare, a part of Thermo Fisher Scientific.
-
Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees and Opens Spring 2023 Submissions
4/17/2023
In support of global initiatives to advance molecular profiling in oncology, Thermo Fisher Scientific announced the latest recipients of the Oncomine Clinical Research Grant and the opening of its submissions for Spring 2023.
-
Thermo Fisher Scientific to Host Investor Day - April 10, 2023
4/10/2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2023 Investor Day on Wednesday, May 24, starting at 9:00 a.m. (ET)in New York City.
-
Thermo Fisher Scientific Expansion in France Boosts Capabilities from Development to Commercial Manufacturing
4/6/2023
Thermo Fisher Scientific, the world leader in serving science, is adding early development work for oral solid dose therapies to its Bourgoin, France site, enabling that location to address customers’ workflow from early drug development through commercial manufacturing and underscoring the company’s commitment to helping clients get medicines to patients sooner.
-
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 26, 2023
4/4/2023
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2023 before the market opens on Wednesday, April 26, 2023, and will hold a conference call on the same day at 8:30 a.m. EST.
-
Thermo Fisher Scientific and Arsenal Biosciences Collaborate to Support Clinical Manufacturing of Autologous T-Cell Therapies
3/29/2023
Thermo Fisher Scientific today announced an update to our strategic collaboration to further the development of manufacturing processes for new cancer treatments.
-
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to Accelerate Development of Breakthrough Therapies
3/27/2023
Thermo Fisher Scientific Inc. and the University of California, San Francisco, will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s Mission Bay campus.
-
Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market
3/21/2023
Stevanato Group S.p.A. announced its collaboration with Thermo Fisher Scientific, the world leader in serving science, to bring to the market a fully integrated on-body delivery system platform for subcutaneous administration.